2026 NPPES data Dermatology Physician NPI 1992111769 MD, PHD
Verify on CMS →

NIL CELEBI CHERUKURI, MD, PHD

Dermatology Physician in WILKES BARRE, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 362 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: NIL CELEBI CHERUKURI, MD, PHD is a Dermatology Physician ([object Object]) practicing in WILKES BARRE, Pennsylvania with a Medicare Part D prescribing footprint of 1K claims across 362 beneficiaries — 14% brand-name prescribing .

What stands out: NIL CELEBI CHERUKURI, MD, PHD filed 1,406 Medicare Part D claims in 2023 across WILKES BARRE, Pennsylvania. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

NIL CELEBI CHERUKURI, MD, PHD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

NIL CELEBI CHERUKURI, MD, PHD at a glance

Quality data not reported

NPI registry status

Active

Issued 07/01/2014

NPI 1992111769

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

1,406 93% vs specialty avg

2023 prescription claims

Specialty avg: 729

Specialty distribution in Pennsylvania

How Dermatology Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers

Dermatology Physician share within Pennsylvania

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within Pennsylvania

Specialty board-certification context

Estimated specialty board-certified rate — Dermatology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Dermatology Physician ABMS/AOA estimate

Est. board-certified rate (Dermatology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Dermatology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NIL CELEBI CHERUKURI, MD, PHD is a Dermatology Physician provider practicing in WILKES BARRE, Pennsylvania, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD, PHD. NPI: 1992111769. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

NIL CELEBI CHERUKURI, MD, PHD appears in the CMS NPPES registry as a Dermatology Physician provider holding MD, PHD credentials at 1155 E MOUNTAIN BLVD, WILKES BARRE, PA, 18702, with a listed phone of (570) 808-6113. NPI 1992111769 was issued on 07/01/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CELEBI CHERUKURI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,406 prescription claims written by this provider, covering 362 Medicare beneficiaries and totaling roughly $1.2 million in drug spend, split 14% brand-name and 86% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1155 E MOUNTAIN BLVD
WILKES BARRE, PA 18702

Provider Details

NPI 1992111769
Specialty Dermatology Physician
Credentials MD, PHD
Gender Female
NPI Issued 07/01/2014

Hospital and facility affiliations

Facilities where NIL CELEBI CHERUKURI, MD, PHD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

GEISINGER CLINIC
WILKES BARRE, PA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to NIL CELEBI CHERUKURI, MD, PHD. To verify NIL CELEBI CHERUKURI, MD, PHD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

NIL CELEBI CHERUKURI, MD, PHD — brand share 14.0%
Specialty average (est.)

14% brand-name claims vs 86% generic, on 1,406 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,406
Total Claims
$1.2M
Total Drug Cost
362
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,647
Total Day Supply
42,218
Brand vs Generic
14% brand / 86% generic
Brand Drug Cost
$1.2M
Generic Drug Cost
$41K
Antibiotic Claims
35

Patient Demographics

Average Patient Age
69.7 years
Avg HCC Risk Score
1.25
Gender Split
58% female / 42% male
Age Distribution
<65: 77, 65-74: 160, 75-84: 105, 85+: 20

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Clobetasol Propionate
193
Ketoconazole
189
Hydrocortisone
186
Triamcinolone Acetonide
177
Mycophenolate Mofetil
62
Clotrimazole
54
Clindamycin Phosphate
49
Taltz Autoinjector
Ixekizumab
39
Otezla
Apremilast
35
Fluorouracil
28

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How NIL CELEBI CHERUKURI, MD, PHD fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

NIL CELEBI CHERUKURI, MD, PHD's 1,406 claims are above the specialty average of 729.

Nearby Dermatology Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as CELEBI CHERUKURI.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NIL CELEBI CHERUKURI, MD, PHD's specialty?
NIL CELEBI CHERUKURI, MD, PHD specializes in Dermatology Physician and practices in WILKES BARRE, Pennsylvania. Credentials: MD, PHD.
How much does NIL CELEBI CHERUKURI, MD, PHD prescribe under Medicare Part D?
In 2023, NIL CELEBI CHERUKURI, MD, PHD wrote 1,406 Medicare Part D claims totaling $1.2M in drug costs for 362 beneficiaries.
Where is NIL CELEBI CHERUKURI, MD, PHD located?
NIL CELEBI CHERUKURI, MD, PHD is located at 1155 E MOUNTAIN BLVD, WILKES BARRE, PA, 18702. Phone: (570) 808-6113.
What is NIL CELEBI CHERUKURI, MD, PHD's NPI number?
NIL CELEBI CHERUKURI, MD, PHD's National Provider Identifier (NPI) is 1992111769, issued on 07/01/2014.
Does NIL CELEBI CHERUKURI, MD, PHD prescribe more brand-name or generic drugs?
NIL CELEBI CHERUKURI, MD, PHD's prescribing is 14% brand-name and 86% generic drugs by claim count, with $1.2M in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does NIL CELEBI CHERUKURI, MD, PHD prescribe most often?
Based on 2023 Medicare Part D data, NIL CELEBI CHERUKURI, MD, PHD's most frequently prescribed drugs include Clobetasol Propionate, Ketoconazole, Hydrocortisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NIL CELEBI CHERUKURI, MD, PHD accept Medicare?
NIL CELEBI CHERUKURI, MD, PHD appears in CMS Medicare data with 1,406 Part D claims and 362 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NIL CELEBI CHERUKURI, MD, PHD's credentials?
NIL CELEBI CHERUKURI, MD, PHD's NPI is 1992111769 with credentials MD, PHD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology